NCT07716995Not yet recruiting
Association Between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
Association between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 127 (estimated)
- First submitted
- 14 Jul 2026
- Start date
- 1 Dec 2026
- Primary completion date
- 1 Feb 2027
- Lead sponsor
- Assiut University
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07716995
What you commit to
- Study type: Observational
- Planned participants: 127
- From 1 Dec 2026 to the primary completion date, 1 Feb 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of alcohol consumption, steroids, proton pump inhibitors, antibiotics, and contraceptive pills
Other illness
- Presence of malignancy
- Patients with lung diseases with hypoxia
Age
- Patients aged ≤18 years old
Other
- Pregnancy
- Type I DM
- Patients with fatty liver who undergone bariatric surgeries.
- Patients with Central sleep apnea, upper airway resistance and narcolepsy
Who the study is looking for
- Patients aged \>18 years old
- presented with a clinical suspicion of sleep-disordered breathing, including snoring, sleepiness and witnessed sleep apnea
Age in the registry: 18 years to 60 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.